Welcome to our dedicated page for Sharps Technology SEC filings (Ticker: STSSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sharps Technology Inc. filings document regulatory disclosures for a Nevada operating company with medical device sales and distribution activities and a Solana-focused digital asset treasury strategy. Current reports describe material agreements, at-the-market equity offering arrangements, executive officer appointments, indemnification agreements, committee changes, and capital-structure matters involving common stock and warrants.
Proxy statements disclose stockholder voting matters, including director elections, auditor ratification, equity incentive plan approvals, and authorization for warrant-related share issuances. The filing record also covers governance procedures, Nasdaq rule considerations, registration-statement use, and securities offering mechanics tied to the company’s common stock and warrant structure.
Sharps Technology, Inc. (STSS) received a large investment from FalconX‑affiliated entities through an August 2025 private placement, and this Schedule 13D discloses their resulting ownership. FalconX Holdings Limited and related vehicles may be deemed to beneficially own about 20.0% of Sharps’ common stock, based on 28,226,153 shares outstanding.
Key investor Solios, Inc. holds warrants deemed to represent about 15.9% beneficial ownership, while MNNC funds hold smaller stakes of 3.2% and 2.2%. The group invested approximately $45.7 million in cash and digital assets, receiving shares plus multiple series of cash and cryptocurrency-funded warrants, some with a 9.99% beneficial ownership cap. The securities were acquired for investment, with no specific change‑of‑control or restructuring plans disclosed.
Sharps Technology, Inc. (STSS) received a large investment from FalconX‑affiliated entities through an August 2025 private placement, and this Schedule 13D discloses their resulting ownership. FalconX Holdings Limited and related vehicles may be deemed to beneficially own about 20.0% of Sharps’ common stock, based on 28,226,153 shares outstanding.
Key investor Solios, Inc. holds warrants deemed to represent about 15.9% beneficial ownership, while MNNC funds hold smaller stakes of 3.2% and 2.2%. The group invested approximately $45.7 million in cash and digital assets, receiving shares plus multiple series of cash and cryptocurrency-funded warrants, some with a 9.99% beneficial ownership cap. The securities were acquired for investment, with no specific change‑of‑control or restructuring plans disclosed.
FalconX-affiliated entities reported significant holdings in Sharps Technology Inc. common stock and warrants on an initial Form 3. MNNC Capital Digital Asset Opportunities Master Fund LP holds 461,538 common shares and MNNC Capital Digital Opportunities BTC Master Fund LP holds 307,692 shares, both indirectly.
Through Solios, Inc., the group also indirectly holds cash and cryptocurrency stapled warrants and pre-funded warrants exercisable into Sharps common stock, including 4,871,192 shares underlying cryptocurrency stapled warrants at an exercise price of $9.75 and 4,871,192 shares underlying cryptocurrency pre-funded warrants at $0.0001, with the pre-funded warrants having no expiration date.
FalconX-affiliated entities reported significant holdings in Sharps Technology Inc. common stock and warrants on an initial Form 3. MNNC Capital Digital Asset Opportunities Master Fund LP holds 461,538 common shares and MNNC Capital Digital Opportunities BTC Master Fund LP holds 307,692 shares, both indirectly.
Through Solios, Inc., the group also indirectly holds cash and cryptocurrency stapled warrants and pre-funded warrants exercisable into Sharps common stock, including 4,871,192 shares underlying cryptocurrency stapled warrants at an exercise price of $9.75 and 4,871,192 shares underlying cryptocurrency pre-funded warrants at $0.0001, with the pre-funded warrants having no expiration date.
Sharps Technology, Inc. received a Schedule 13G from Bastion Trading Limited, Bastion Holdings Limited, and Wei Zhu reporting passive ownership of common stock. The Reporting Persons collectively report beneficial ownership of 3,615,046 shares of common stock, representing a 9.99% stake in the company. Due to EDGAR field limits, this percentage is shown as 9.9% on the cover pages.
Bastion Trading directly holds 1,428,394 common shares, as well as pre-funded warrants for up to 4,234,615 shares and additional warrants for up to 5,384,615 shares. These warrants are subject to a beneficial ownership blocker that prevents exercises which would push ownership above 9.99% of outstanding common stock. The ownership percentage is based on an estimated 34,000,000 shares outstanding plus 2,186,652 shares issuable upon warrant exercise within 60 days. The Reporting Persons certify the holdings are not for the purpose of changing or influencing control of Sharps Technology.
Sharps Technology, Inc. received a Schedule 13G from Bastion Trading Limited, Bastion Holdings Limited, and Wei Zhu reporting passive ownership of common stock. The Reporting Persons collectively report beneficial ownership of 3,615,046 shares of common stock, representing a 9.99% stake in the company. Due to EDGAR field limits, this percentage is shown as 9.9% on the cover pages.
Bastion Trading directly holds 1,428,394 common shares, as well as pre-funded warrants for up to 4,234,615 shares and additional warrants for up to 5,384,615 shares. These warrants are subject to a beneficial ownership blocker that prevents exercises which would push ownership above 9.99% of outstanding common stock. The ownership percentage is based on an estimated 34,000,000 shares outstanding plus 2,186,652 shares issuable upon warrant exercise within 60 days. The Reporting Persons certify the holdings are not for the purpose of changing or influencing control of Sharps Technology.
Sharps Technology, Inc. received an updated ownership report showing that funds advised by Saba Capital Management, together with related entities and Boaz R. Weinstein, beneficially own 3,050,450 shares of common stock and warrants, representing 9.99% of the class. The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025 plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons, as referenced in a recent prospectus.
The reporting group states that the securities are not held for the purpose or effect of changing or influencing control of Sharps Technology and are not part of any control-related transaction, other than activities solely in connection with a board nomination process allowed under relevant rules. Dividends and sale proceeds from these securities are payable to the funds and accounts advised by Saba Capital.
Sharps Technology, Inc. received an updated ownership report showing that funds advised by Saba Capital Management, together with related entities and Boaz R. Weinstein, beneficially own 3,050,450 shares of common stock and warrants, representing 9.99% of the class. The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025 plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons, as referenced in a recent prospectus.
The reporting group states that the securities are not held for the purpose or effect of changing or influencing control of Sharps Technology and are not part of any control-related transaction, other than activities solely in connection with a board nomination process allowed under relevant rules. Dividends and sale proceeds from these securities are payable to the funds and accounts advised by Saba Capital.
Saba Capital Management, L.P., a more than 10% owner of Sharps Technology Inc. (STSS), reported selling common stock in two transactions. On January 15, 2026, it sold 25,000 shares at $2.30 per share. On January 16, 2026, it sold an additional 12,182 shares at $2.37 per share.
After these sales, Saba Capital Management, L.P. beneficially owned 1,511,988 shares of Sharps Technology common stock, held indirectly. The filing notes that, as a result of the January 16, 2026 disposition, the reporting person now owns less than 10% of the issuer’s outstanding shares.
Saba Capital Management, L.P., a more than 10% owner of Sharps Technology Inc. (STSS), reported selling common stock in two transactions. On January 15, 2026, it sold 25,000 shares at $2.30 per share. On January 16, 2026, it sold an additional 12,182 shares at $2.37 per share.
After these sales, Saba Capital Management, L.P. beneficially owned 1,511,988 shares of Sharps Technology common stock, held indirectly. The filing notes that, as a result of the January 16, 2026 disposition, the reporting person now owns less than 10% of the issuer’s outstanding shares.
Sharps Technology, Inc. filed a Definitive Proxy Statement asking shareholders to vote on four proposals at a special meeting, principally the approval to issue up to 49,673,120 shares of common stock upon exercise of outstanding Cryptocurrency Warrants and a separate approval for issuance upon exercise of Strategic Advisor Warrants. The filing lists board nominees and executive officers, including Paul K. Danner as Executive Chairman and Principal Executive Officer and Andrew R. Crescenzo as CFO. The statement notes the threshold rule that an issuance equaling or exceeding 20% of outstanding common stock requires shareholder approval. Specific beneficial ownership lines are summarized with individual directors and officers holding less than 1% each.
Sharps Technology Inc. filed a preliminary proxy statement for a special meeting addressing several proposals. Shareholders are asked to elect Annemarie Tierney as a director to serve until the 2026 annual meeting. The company seeks approval under Nasdaq Listing Rule 5635(a) to issue unspecified numbers of common shares upon the exercise of multiple warrant arrangements, including "Cryptocurrency Warrants," "Strategic Advisor Warrants," pre-funded warrants and stapled warrants; the exact share amounts are redacted or shown as placeholders. Other agenda items include adjournment and transacting other proper business at the special meeting. The filing lists named officers and directors including Paul K. Danner (Executive Chairman and Principal Executive Officer), Andrew R. Crescenzo (CFO), and Yuwen (Alice) Zhang (Chief Investment Officer and Director). Several sections and numeric details appear incomplete or redacted in the provided excerpt.
Sharps Technology, Inc. entered into a Controlled Equity Offering Sales Agreement allowing it to sell, from time to time, up to $236,605,575 of its common stock through at-the-market offerings. Cantor Fitzgerald & Co. will act as principal and sole designated sales agent, with Aegis Capital Corp. also named as an agent, and will receive a 3.0% commission on gross proceeds from each sale. The company is not obligated to sell any shares and may suspend or terminate the program at any time. Any shares sold will be issued under existing shelf registration statements on Form S-3 and a prospectus supplement dated September 2, 2025.
Sharps Technology, Inc. is registering an at-the-market program to sell up to $236,605,575 of common stock through Cantor Fitzgerald and Aegis. Shares may be issued from time to time on Nasdaq under symbol STSS at prevailing prices, with a 3% sales commission to the agents.
The company plans to use any proceeds for general corporate purposes and, importantly, to pursue a new Solana (SOL)-focused digital asset treasury strategy, including SOL acquisitions and staking. Recent PIPE financings using cash and SOL, large warrant packages, and new leadership hires support this shift, but also introduce substantial dilution risk and exposure to highly volatile cryptocurrency markets.
Sharps Technology Inc. reported a material event describing issuance mechanics for warrants tied to a transaction: Strategic Advisor Warrants equal to 10% of the combined Cash Shares and Pre-Funded Warrant Shares, and upon exercise of each Stapled Warrant the Strategic Advisor receives additional warrants equal to 10% of the Stapled Warrant Shares exercised. The Strategic Advisor Warrants allow purchase of Common Stock (referred to as Strategic Advisor Warrant Shares). The filing discloses that Sol Markets, which is controlled by James Zhang, is related by family to the company through Alice Zhang, the company’s Chief Investment Officer and a Director. A company website link is provided.